Gut Enzymes Fingered in Some 5-ASA Treatment Failures : vima

Patients with inflammatory bowel disease who had three or four specific acetyltransferases in their gut microbiota had a threefold higher risk for 5-ASA treatment failure.

Related Keywords

Boston , Massachusetts , United States , Netherlands , Nijmegen , Gelderland , American , Michaelj Rosen , Raajs Mehta , , American College Of Gastroenterology , Pfizer , Pcrohn Colitis Congress , Stanford University Medical Center , Crohn Colitis Foundation , National Institutes Of Health , American Gastroenterological Association , Massachusetts General Hospital , Colitis Congress , Colitis Foundation , American Gastroenterological , Radboud Hospital , Human Microbiome Project , Palo Alto , National Institutes , American College , Inflammatory Bowel Disease , Nflammatory Bowel Disease Ibd , Bd , Colitis , Microbiome , Hospitals , Steroids , Liquid Biopsy , Luid Biopsy , Luid Phase Biopsy , Cancer Blood Test , Ancer Saliva Test , Lood Biopsy , Erum Biopsy , Ulcerative Colitis , Crohns Disease , Bacteria , Biopsy , Blood , Children , Child , Childhood , Ediatrics , Kids , Corticosteroid , Fellowship , Yellows , Fingers , Genomics , Genomic Medicine , Medici ,